Moderna’s mNEXSPIKE mRNA COVID-19 Shot Approved by European Commission
The European Commission (EC) has granted marketing authorization for Moderna’s mNEXSPIKE mRNA COVID-19 shot, allowing it to be marketed across the European Union (U.N.). The authorization follows a regulatory review and permits all 27 E.U. Member States, as well as Iceland, Liechtenstein and Norway, to consider the shot for use within their vaccination programs. It […]
“Profound Autism” Under Consideration as New Diagnosis
Autism has emerged as one of the most intensely debated public health issues over the past three decades, but especially during the past year. U.S. Secretary of Health and Human Services Robert F. Kennedy, Jr. has vowed to launch a sweeping research initiative aimed at identifying underlying causes of autism—a move applauded by some advocates […]
Combination mRNA COVID-Influenza Shot Recommended by European Medicines Agency
The European Medicine Agency (EDA) has recommended marketing authorization for Moderna’s mCombriax mRNA (messenger ribonucleic acid) shot. The product, also known as mRNA-1083, is a genetically engineered biologic targeting both influenza and COVID-19. It builds on work Moderna has done on its next-generation mRNA COVID shot known as mNexSpike and mRNA-1010.1 2 3 The recommendation […]
FDA Greenlights Review of Moderna’s mRNA Flu Shot After Application Amended
On Feb. 18, 2026, the U.S. Food and Drug Administration (FDA) agreed to review Moderna’s application for its mRNA influenza shot, known as mRNA-1010, after the company amended its submission to address regulatory concerns. The agency accepted the updated biologics license application and set a target action date of Aug. 5, 2026, allowing the shot […]
Vaccine Freedom Bills Surging Across U.S.
With more than 700+ vaccine-related bills advancing in state legislatures, Dawn Richardson, Director of Advocacy at NVIC, breaks down the key policy battles shaping the post-COVID health landscape. From exemption challenges to liability proposals, the legislative decisions unfolding now could directly impact families in every state. If you would like to receive an e-mail notice […]
Government Expands U.S. Glyphosate Production and Liability Protections
President Trump issued an Executive Order on Feb. 18, 2026 prioritizing domestic production of glyphosate, the primary ingredient in the herbicide Roundup, calling it critical to national security. Glyphosate has been the subject of extensive litigation in recent years and has been classified as “probably carcinogenic to humans” by some international health agencies, including the […]